Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA: FCM Imaging for Conduction Tissue Identification in Heart Surgery
NCT04017975Phase 2Unknown
- Start
- Dec 2019
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Ventricular Septal Defect (VSD), atrioventricular septal defect (AVSD) and tetralogy of Fallot (TOF) (2 cohorts). Primary endpoint: Rate of new conduction disorders. Status: unknown.
02
Conditions
Ventricular Septal Defect (VSD)atrioventricular septal defect (AVSD)tetralogy of Fallot (TOF)
Beyond the preview
Go deeper on NCT04017975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017975.